首页> 外文期刊>Current drug safety >Debating the Evidence: Oral Contraceptives Containing Drospirenone and Risk of Blood Clots
【24h】

Debating the Evidence: Oral Contraceptives Containing Drospirenone and Risk of Blood Clots

机译:辩论的证据:含屈螺酮的口服避孕药和血栓风险

获取原文
获取原文并翻译 | 示例
           

摘要

Skepticism is an essential quality in science. We doubt, re-examine and demand the highest quality of evidence. However, sometimes this puts us in an awkward situation. How much evidence do we need before we act? This dilemma is a constant problem in drug safety. Treatment decisions are always a balance of risks and benefits and there may be a paucity of evidence about rare or very rare adverse events.
机译:怀疑论是科学的基本素质。我们怀疑,重新审查并要求提供最高质量的证据。但是,有时这使我们处于尴尬的境地。我们采取行动之前需要多少证据?这个难题是药物安全性中的一个长期问题。治疗决策始终是风险与收益之间的平衡,并且可能很少有证据表明罕见或非常罕见的不良事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号